Despite these limitations, our findings highlight the potential of radiologically defined sarcopenia as a clinically relevant predictor of pCR, especially in HER2-positive and TNBC subtypes, where achieving pCR has clear prognostic value. This evidence concerns the gene ERBB2 and sarcopenia.